FDA approves Freenome's blood test for colorectal cancer screening

By Sahil Pandey July 27 (Reuters) - The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for ...

Freenome secures FDA nod for blood-based colorectal cancer test

Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will ...
American Cancer Society

What You Need to Know About the Latest Colorectal Cancer Screening Recommendations

The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...
MPR

SimpleScreen CRC Blood-Based Screening Test Receives FDA Approval

Freenome's newly approved blood test offers clinicians an alternative screening option for average-risk adults aged 45 and ...
Medscape

A New CRC Blood Test Is Here. What Does It Mean for Screening?

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
The Manila Times

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

Freenome is a biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.- Approval expands colorectal cancer screening options for the up to 6 ...